InvestorsHub Logo
Followers 59
Posts 11482
Boards Moderated 0
Alias Born 07/16/2006

Re: None

Thursday, 09/13/2018 4:27:34 PM

Thursday, September 13, 2018 4:27:34 PM

Post# of 20689
Momenta assumed with a Buy at Stifel

Stifel analyst Derek Archila assumed Momenta with a Buy rating and a price target of $40, saying the stock offers an investment in an "exciting biotech company that has a pipeline with demonstrated proof-of-mechanism". The analyst expects sentiment on Momenta to shift as it "completes its strategic review, ideally sheds costs/potentially monetizes its legacy businesses, and narrows its focus on its proprietary pipeline M281 and M254.

Read more at:
https://thefly.com/landingPageNews.php?id=2790363